Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

High prevalence of morphological subtype FAB M1 in adults with de novo acute myeloid leukemia in São José dos Campos, São Paulo.

Callera F, Mulin CC, Rosa ES, Melo DB, Melo CM.

Sao Paulo Med J. 2006 Jan 5;124(1):45-7. Epub 2006 Apr 3.

2.
3.

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.

Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.

Eur J Haematol. 2004 Feb;72(2):89-106.

PMID:
14962246
4.

Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.

Heinonen K, Mrózek K, Lawrence D, Arthur DC, Pettenati MJ, Stamberg J, Qumsiyeh MB, Verma RS, MacCallum J, Schiffer CA, Bloomfield CD.

Br J Haematol. 1998 Jun;101(3):513-20.

PMID:
9633896
5.

[Prognostic significance of CD7 expression in adult acute myeloid leukemia].

Saito T, Usui N, Dobashi N, Maki N, Asai O, Yano S, Kato A, Watanabe H, Katori M, Nagamine M, Ogihara A, Yamazaki H, Kobayashi T, Tajima N, Kuraishi Y.

Rinsho Ketsueki. 1998 Jul;39(7):481-6. Japanese.

PMID:
9750454
6.

Long-term outcomes of de novo acute myeloid leukemia in Thai patients.

Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.

J Med Assoc Thai. 2009 Sep;92(9):1143-9.

PMID:
19772172
7.

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.

Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG; Children's Oncology Group.

Pediatr Blood Cancer. 2007 Jul;49(1):17-22.

PMID:
16856158
8.

Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.

Harani MS, Adil SN, Shaikh MU, Kakepoto GN, Khurshid M.

J Ayub Med Coll Abbottabad. 2005 Jan-Mar;17(1):26-9.

PMID:
15929522
9.

Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

Blum W, Mrózek K, Ruppert AS, Carroll AJ, Rao KW, Pettenati MJ, Anastasi J, Larson RA, Bloomfield CD.

Cancer. 2004 Sep 15;101(6):1420-7. Review.

10.

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

Medeiros BC, Minden MD, Schuh AC, Schimmer AD, Yee K, Lipton JH, Messner HA, Gupta V, Chun K, Xu W, Das P, Kamel-Reid S, Brandwein JM.

Leuk Lymphoma. 2007 Jan;48(1):65-71.

PMID:
17325849
11.

High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.

Am J Hematol. 2005 May;79(1):26-35.

12.

Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review.

Kuriyama K, Tomonaga M, Kobayashi T, Takeuchi J, Ohshima T, Furusawa S, Saitoh K, Ohno R; Japan Adult Leukemia Study Group.

Int J Hematol. 2001 Jan;73(1):93-9.

PMID:
11372762
13.

The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.

Lima CS, Vassalo J, Lorand-Metze I, Bechelli AP, Souza CA.

Haematologia (Budap). 1997;28(2):85-95.

PMID:
9283908
14.

Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia.

Mertelsmann R, Tzvi Thaler H, To L, Gee TS, McKenzie S, Schauer P, Friedman A, Arlin Z, Cirrincione C, Clarkson B.

Blood. 1980 Nov;56(5):773-81.

16.

Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.

Brito-Babapulle F, Catovsky D, Galton DA.

Br J Haematol. 1987 Aug;66(4):445-50.

PMID:
3478074
17.

[Clinical analysis of HLA-DR-negative non-M3 AML].

Mori H, Sakai H, Sanada M, Shimamoto K, Sasaki S, Azuma R, Higuchi T, Harada H, Niikura H, Omine M, Fujita K, Takahashi N.

Rinsho Ketsueki. 2007 Jul;48(7):547-53. Japanese.

PMID:
17695303
18.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

19.

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.

Ruan GR, Li JL, Qin YZ, Li LD, Xie M, Chang Y, Zhang Y, Liu YR, Jiang B, Chen SS, Huang XJ.

Ann Hematol. 2009 Feb;88(2):159-66. doi: 10.1007/s00277-008-0591-8. Epub 2008 Aug 23.

PMID:
18726096
20.

Analysis of the presenting features of adult acute leukemia: the French-American-British classification.

Burns CP, Armitage JO, Frey AL, Dick FR, Jordan JE, Woolson RF.

Cancer. 1981 May 15;47(10):2460-9.

Supplemental Content

Support Center